Clinical Trial Update: A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema [Phase 2, Phase 3]

View source ↗

Summary

A continuation study of the AeriSeal System for lung volume reduction in patients with advanced emphysema was terminated after Phase 2/3 enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• AeriSeal System

Snippet

Sponsor: Aeris Therapeutics | Conditions: Pulmonary Emphysema, Chronic Obstructive Pulmonary Disease(COPD) | Phase 2, Phase 3 | Status: TERMINATED